H.
Christopher Owings
Assistant
Director
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street, NE
Mail
Stop #3561
Washington,
DC 20549
|
10.
|
We
note your response to comment 48 in our letter dated June 7,
2007. Based on paragraph B93 of SFAS 123R, compensation expense
should be based on the grant date fair value of the award, which
in
concept includes the present value of dividends. However, since
you subtract the present value of dividends in calculating compensation
cost at the grant date and you do not give effect to the dividend
shares
that will be issued when the restrictions lapse, it appears you are
understating compensation expense. Based on the above cite, it
appears you should subtract the present value of dividends in calculating
compensation expense only in those circumstances in which the employee
forgoes the dividend during the restricted period and does not receive
additional shares or cash. In your case, the employee receives
dividends that were earned during the restricted period. Please
revise your accounting or, if you do not agree, explain to us in
detail
how your accounting complies with paragraph B93 of SFAS
123R.
|
11.
|
We
note your response to comment 50 in our letter dated June 7, 2007,
and we
note you concluded that the forward sale agreement qualifies for
the scope
exception in paragraph 11.a of SFAS 133. As the settlement
amount of the forward sale agreement is based, in part, on a floating
interest factor equal to the federal funds rate less a fixed spread,
please explain to us in detail how you concluded this instrument
is
indexed solely to your own stock, as contemplated
in paragraph 11.a.(1) of SFAS 133. In your response, please
explain your consideration of the guidance in paragraph 286 of SFAS
133,
which requires derivative treatment for contracts that provide for
settlement in shares of an entity’s stock but that are indexed in part to
something other than the entity’s
stock.
|
·
|
The
Emerging Issues Task Force (EITF) has had EITF 02-D on its agenda
since
early 2002. Currently, EITF Issue 02-D is pending further
progress on Phase II of the Board’s liabilities and equity
project.
|
·
|
In
deliberating EITF 01-6, the task forced noted that “Even though the points
in the above FAS 133 Implementation Issues appear clear, there continues
to be some ambiguity in what indexed only to a company's own stock
means
in FAS 133. Specifically, the decision by a holder of
convertible debt whether to exercise the conversion option is based
upon
several factors. Some of those factors may include the current
stock price, the current dividend yield, and the projected stock
price –
all of which appear to be consistent with the criteria that the conversion
option is indexed to a company's own stock. However, other
factors may include the current interest rate environment, the credit
rating of the company, and the forecasted interest rate environment
– all
of which appear to be inconsistent with the criteria that the conversion
option is indexed to a company's own stock. Despite
those factors that may affect the holder's decision of whether to
exercise
the conversion option, paragraph 61(k) of FAS 133 indicates that
when an
entity issues debt that is convertible into its own stock, the issuing
entity qualifies for the exception in paragraph 11(a) because a separate
option with the same terms would not be considered a
derivative.” [emphasis added]1
|
|
price
that increases on a daily basis by the overnight Fed Funds rate (as
opposed to a forward price that is determined based on the interest
rate
environment on the date the contract is entered into)” are specifically
identified as warranting
consideration.
|